These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 37477132)
1. Nucleolin‑based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review). Thongchot S; Aksonnam K; Thuwajit P; Yenchitsomanus PT; Thuwajit C Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37477132 [TBL] [Abstract][Full Text] [Related]
2. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Reyes-Reyes EM; Teng Y; Bates PJ Cancer Res; 2010 Nov; 70(21):8617-29. PubMed ID: 20861190 [TBL] [Abstract][Full Text] [Related]
3. The roles of nucleolin subcellular localization in cancer. Berger CM; Gaume X; Bouvet P Biochimie; 2015 Jun; 113():78-85. PubMed ID: 25866190 [TBL] [Abstract][Full Text] [Related]
4. Human anti-nucleolin recombinant immunoagent for cancer therapy. Palmieri D; Richmond T; Piovan C; Sheetz T; Zanesi N; Troise F; James C; Wernicke D; Nyei F; Gordon TJ; Consiglio J; Salvatore F; Coppola V; Pichiorri F; De Lorenzo C; Croce CM Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9418-23. PubMed ID: 26170308 [TBL] [Abstract][Full Text] [Related]
5. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis. Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538 [TBL] [Abstract][Full Text] [Related]
6. Regulation of nucleolin expression by miR-194, miR-206, and HuR. Bose S; Tholanikunnel TE; Reuben A; Tholanikunnel BG; Spicer EK Mol Cell Biochem; 2016 Jun; 417(1-2):141-53. PubMed ID: 27221739 [TBL] [Abstract][Full Text] [Related]
7. AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin. Cheng Y; Zhao G; Zhang S; Nigim F; Zhou G; Yu Z; Song Y; Chen Y; Li Y PLoS One; 2016; 11(12):e0167094. PubMed ID: 27907160 [TBL] [Abstract][Full Text] [Related]
8. Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancer. Wolfson E; Goldenberg M; Solomon S; Frishberg A; Pinkas-Kramarski R Oncotarget; 2016 Oct; 7(40):65320-65334. PubMed ID: 27542246 [TBL] [Abstract][Full Text] [Related]
9. In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. Pichiorri F; Palmieri D; De Luca L; Consiglio J; You J; Rocci A; Talabere T; Piovan C; Lagana A; Cascione L; Guan J; Gasparini P; Balatti V; Nuovo G; Coppola V; Hofmeister CC; Marcucci G; Byrd JC; Volinia S; Shapiro CL; Freitas MA; Croce CM J Exp Med; 2013 May; 210(5):951-68. PubMed ID: 23610125 [TBL] [Abstract][Full Text] [Related]
10. Aptamer AS1411 utilized for super-resolution imaging of nucleolin. Jing Y; Cai M; Zhou L; Jiang J; Gao J; Wang H Talanta; 2020 Sep; 217():121037. PubMed ID: 32498876 [TBL] [Abstract][Full Text] [Related]
11. Roles of nucleolin. Focus on cancer and anti-cancer therapy. Chen Z; Xu X Saudi Med J; 2016 Dec; 37(12):1312-1318. PubMed ID: 27874146 [TBL] [Abstract][Full Text] [Related]
12. Nucleolin Promotes IRES-Driven Translation of Foot-and-Mouth Disease Virus by Supporting the Assembly of Translation Initiation Complexes. Han S; Wang X; Guan J; Wu J; Zhang Y; Li P; Liu Z; Abdullah SW; Zhang Z; Jin Y; Sun S; Guo H J Virol; 2021 Jun; 95(13):e0023821. PubMed ID: 33853964 [TBL] [Abstract][Full Text] [Related]
13. Cellular localization of nucleolin determines the prognosis in cancers: a meta-analysis. Yangngam S; Prasopsiri J; Hatthakarnkul P; Thongchot S; Thuwajit P; Yenchitsomanus PT; Edwards J; Thuwajit C J Mol Med (Berl); 2022 Aug; 100(8):1145-1157. PubMed ID: 35861882 [TBL] [Abstract][Full Text] [Related]
14. "Light-On" Fluorescent Nanoprobes for Monitoring Dynamic Distribution of Cellular Nucleolin During Pyroptosis. Kong J; Ju X; Qi G; Wang J; Diao X; Wang B; Zhang C; Li J; Jin Y Anal Chem; 2024 Jan; 96(2):926-933. PubMed ID: 38158373 [TBL] [Abstract][Full Text] [Related]
15. Anti-nucleolin Aptamer as a Boom in Rehabilitation of Breast Cancer. Janani SK; Dhanabal SP; Sureshkumar R; Nikitha Upadhyayula SS Curr Pharm Des; 2022; 28(38):3114-3126. PubMed ID: 36173049 [TBL] [Abstract][Full Text] [Related]
16. AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation. Iturriaga-Goyon E; Vivanco-Rojas O; Magaña-Guerrero FS; Buentello-Volante B; Castro-Salas I; Aguayo-Flores JE; Gracia-Mora I; Rivera-Huerta M; Sánchez-Bartés F; Garfias Y Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884955 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation. Reyes-Reyes EM; Šalipur FR; Shams M; Forsthoefel MK; Bates PJ Mol Oncol; 2015 Aug; 9(7):1392-405. PubMed ID: 25911416 [TBL] [Abstract][Full Text] [Related]
18. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin. Teng Y; Girvan AC; Casson LK; Pierce WM; Qian M; Thomas SD; Bates PJ Cancer Res; 2007 Nov; 67(21):10491-500. PubMed ID: 17974993 [TBL] [Abstract][Full Text] [Related]
19. The implications and mechanisms of the extra-nuclear nucleolin in the esophageal squamous cell carcinomas. Qi J; Li H; Liu N; Xing Y; Zhou G; Wu Y; Liu Y; Chen W; Yue J; Han B; Kang S; Wu X Med Oncol; 2015 Mar; 32(3):45. PubMed ID: 25631630 [TBL] [Abstract][Full Text] [Related]
20. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Soundararajan S; Wang L; Sridharan V; Chen W; Courtenay-Luck N; Jones D; Spicer EK; Fernandes DJ Mol Pharmacol; 2009 Nov; 76(5):984-91. PubMed ID: 19657047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]